SHENZHEN, China, Feb. 21, 2022 /PRNewswire/ — Not too long ago, the silver alginate dressing of Winner Medical (300888.SZ) receives U.S. FDA market entry (510K Quantity: K202982), marking that this product has obtained the qualification to get into the entry US market and Winner Medical will additional develop its enterprise in North America.
It’s understood that the silver alginate dressing consists of calcium alginate and silver particles, which may take in wound exudate and repeatedly launch silver ions within the presence of wound fluid, and it could possibly successfully kill and inhibit the microbial colonization of wounds. The antibacterial price is 99.99%, and it may be used for as much as 7 days. The alginate absorbs the wound exudate and varieties a gel to take care of the moist surroundings of the wound.
This product has very distinctive options. It varieties a gel after absorbing wound exudate to take care of a moist therapeutic surroundings on the wound floor; it’s broad-spectrum antibacterial and repeatedly releases silver ions with an impact of 99.99% and can be utilized for as much as 7 days; silver alginate dressing is appropriate for average to extreme contaminated wounds, together with postoperative wounds, trauma wounds, calf ulcers, strain ulcers, diabetic ulcers, grafts and donor websites.
The FDA’s approval of Winner Medical’s silver alginate sequence merchandise can be useful to additional enhance market competitiveness on this subject, and can play a constructive function in promotion and product gross sales in abroad market.
View unique content material to obtain multimedia:https://www.prnewswire.com/news-releases/winner-silver-alginate-dressing-has-obtained-510k-code-in-the-usa-301487007.html
SOURCE Winner Medical Co., Ltd.